Relationships between respiration and susceptibility to azole antifungals in Candida glabrata
- PMID: 12604511
- PMCID: PMC149308
- DOI: 10.1128/AAC.47.3.847-853.2003
Relationships between respiration and susceptibility to azole antifungals in Candida glabrata
Abstract
Over the past two decades, the incidence of infections due to Candida glabrata, a yeast with intrinsic low susceptibility to azole antifungals, has increased markedly. Respiratory deficiency due to mutations in mitochondrial DNA (mtDNA) associated with resistance to azoles frequently occurs in vitro in this species. In order to specify the relationships between respiration and azole susceptibility, the effects of respiratory chain inhibitors on a wild-type isolate of C. glabrata were evaluated. Respiration of blastoconidia was immediately blocked after extemporaneous addition of potassium cyanide, whereas a 4-h preincubation was required for sodium azide. Antifungal susceptibility determined by a disk diffusion method on Casitone agar containing sodium azide showed a significant decrease in the susceptibility to azoles. Biweekly subculturing on Casitone agar supplemented with sodium azide was therefore performed. This resulted after 40 passages in the isolation of a respiration-deficient mutant, as suggested by its lack of growth on glycerol-containing agar. This respiratory deficiency was confirmed by flow cytometric analysis of blastoconidia stained with rhodamine 123 and by oxygraphy. Moreover, transmission electron microscopy and restriction endonuclease analysis of the mtDNA of mutant cells demonstrated the mitochondrial origin of the respiratory deficiency. Finally, this mutant exhibited cross-resistance to all the azoles tested. In conclusion, blockage of respiration in C. glabrata induces decreased susceptibility to azoles, culminating in azole resistance due to the deletion of mtDNA. This mechanism could explain the induction of petite mutations by azole antifungals which have been demonstrated to act directly on the mitochondrial respiratory chain.
Figures






Similar articles
-
Relationship between respiration deficiency and azole resistance in clinical Candida glabrata.FEMS Yeast Res. 2012 Sep;12(6):719-27. doi: 10.1111/j.1567-1364.2012.00821.x. Epub 2012 Jul 11. FEMS Yeast Res. 2012. PMID: 22713096
-
Hypersusceptibility to azole antifungals in a clinical isolate of Candida glabrata with reduced aerobic growth.Antimicrob Agents Chemother. 2009 Jul;53(7):3034-41. doi: 10.1128/AAC.01384-08. Epub 2009 Apr 20. Antimicrob Agents Chemother. 2009. PMID: 19380598 Free PMC article.
-
In-vivo selection of an azole-resistant petite mutant of Candida glabrata.J Med Microbiol. 2000 Nov;49(11):977-984. doi: 10.1099/0022-1317-49-11-977. J Med Microbiol. 2000. PMID: 11073151
-
Resistance in human pathogenic yeasts and filamentous fungi: prevalence, underlying molecular mechanisms and link to the use of antifungals in humans and the environment.Dan Med J. 2016 Oct;63(10):B5288. Dan Med J. 2016. PMID: 27697142 Review.
-
Candida glabrata--unique features and challenges in the clinical management of invasive infections.Mycoses. 2015 Aug;58(8):445-50. doi: 10.1111/myc.12348. Mycoses. 2015. PMID: 26207423 Review.
Cited by
-
Determination of antifungal susceptibility patterns among the clinical isolates of Candida species.J Glob Infect Dis. 2011 Oct;3(4):357-60. doi: 10.4103/0974-777X.91059. J Glob Infect Dis. 2011. PMID: 22223999 Free PMC article.
-
A Putative Mitochondrial Iron Transporter MrsA in Aspergillus fumigatus Plays Important Roles in Azole-, Oxidative Stress Responses and Virulence.Front Microbiol. 2016 May 12;7:716. doi: 10.3389/fmicb.2016.00716. eCollection 2016. Front Microbiol. 2016. PMID: 27433157 Free PMC article.
-
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Front Microbiol. 2017 Jan 12;7:2173. doi: 10.3389/fmicb.2016.02173. eCollection 2016. Front Microbiol. 2017. PMID: 28127295 Free PMC article. Review.
-
Overexpression of the White Opaque Switching Master Regulator Wor1 Alters Lipid Metabolism and Mitochondrial Function in Candida albicans.J Fungi (Basel). 2022 Sep 28;8(10):1028. doi: 10.3390/jof8101028. J Fungi (Basel). 2022. PMID: 36294593 Free PMC article.
-
In vivo systematic analysis of Candida albicans Zn2-Cys6 transcription factors mutants for mice organ colonization.PLoS One. 2011;6(10):e26962. doi: 10.1371/journal.pone.0026962. Epub 2011 Oct 31. PLoS One. 2011. PMID: 22073120 Free PMC article.
References
-
- Aoki, S., and S. Ito-Kuwa. 1987. Induction of petite mutation with acriflavine and elevated temperature in Candida albicans. J. Med. Vet. Mycol. 25:269-277. - PubMed
-
- Baddley, J. W., A. M. Smith, S. A. Moser, and P. G. Pappas. 2001. Trends in frequency and susceptibilities of Candida glabrata bloodstream isolates at a university hospital. Diagn. Microbiol. Infect. Dis. 39:199-201. - PubMed
-
- Beck-Sague, C. M., and W. R. Jarvis. 1993. Secular trends in the epidemiology of nosocomial fungal infections in the United States, 1980-1990. National Nosocomial Infections Surveillance System. J. Infect. Dis. 167:1247-1251. - PubMed
-
- Bodey, G. P., M. Mardani, H. A. Hanna, M. Boktour, J. Abbas, E. Girgawy, R. Y. Hachem, D. P. Kontoyiannis, and I. I. Raad. 2002. The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer. Am. J. Med. 112:380-385. - PubMed
-
- Bouchara, J. P., R. Zouhair, S. Le Boudouil, G. Renier, R. Filmon, D. Chabasse, J. N. Hallet, and A. Defontaine. 2000. In vivo selection of an azole-resistant petite mutant of Candida glabrata. J. Med. Microbiol. 49:977-984. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous